IPO - Gelteq Ltd

Form Type: F-1

Filing Date: 2025-07-01

Corporate Action: Ipo

Type: New

Accession Number: 000121390025059880

Filing Summary: Gelteq Limited has filed a registration statement on Form F-1 with the SEC to register the resale of up to 4,000,000 ordinary shares, no par value, by Lincoln Park Capital Fund, LLC. This follows their IPO on October 30, 2024, where they raised $5.2 million by offering 1,300,000 ordinary shares at $4.00 each. The company focuses on gel-based delivery solutions in various sectors including pharmaceuticals and nutraceuticals. The selling shareholder, Lincoln Park, has a purchase agreement that allows Gelteq to sell shares up to $12 million, with a portion already issued as Commitment Shares. The document notes, risks of investment in their shares and the nature of being an emerging growth company under the JOBS Act, allowing for reduced reporting requirements. As of the registration, Gelteq maintains its operation in Australia with shares listed on Nasdaq under the symbol 'GELS'.